Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1CNS 1

Conditions

Pheochromocytoma 2Neuroblastoma 2Paraganglioma 1Neuroendocrine Tumors 1

Interventions

gallium Ga 68 dotatate 4lutetium Lu 177 dotatate 2belzutifan 2Fluorodeoxyglucose F18 2olaparib 1fludarabine phosphate 1Specimen Handling 1Phenoxybenzamine 1ONC206 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Genetic Testing 1Cyclophosphamide 1Blood Specimen Collection 1Biopsy 13-fluorobenzylguanidine 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Paraganglioma × 3-fluorobenzylguanidine × Clear all
NCT05069220 2024-03-01

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Recruiting
150 enrolled
CNSEndocrineNET

Neuroblastoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡